MUSTANG BIO, INC. (Nasdaq:MBIO)
Health Care/Life Sciences • Biotechnology
CIK 1680048
Company
Mustang Bio, Inc. is a clinical-stage biopharmaceutical company, which engages in the translation of medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline includes CAR T therapies for hematologic malignancies, CAR T therapies for solid tumors, and gene therapies for rare genetic disorders. The company was founded on March 13, 2015 and is headquartered in Worcester, MA.
Address
377 Plantation Street
1st floor
Worcester, Massachusetts 01605-2245
377 Plantation Street
1st floor
Worcester, Massachusetts 01605-2245
Employees
80
80
Stock Info
Close
$1.7100
$1.7100
Day Range
1.5000 - 1.7533
1.5000 - 1.7533
52 Week Range
1.5000 - 74.5000
1.5000 - 74.5000
Average volume
306.43K
306.43K
Short Interest
118.22K (02/14/25)
118.22K (02/14/25)
% of Float Shorted
8.23%
8.23%
Market Cap
$4.71M
$4.71M
Revenue
N/A
N/A
Net Income
-$51.6M
-$51.6M
2020 Sales Growth
N/A
N/A
Key Executives
Board Of Directors
Executive Chairman Michael Sean Weiss |
Non-Executive Director Lindsay Allan Rosenwald |
Independent Director Michael J. Zelefsky |
Independent Non-Executive Director Adam Jeremy Chill |
Independent Director David Jin |
Independent Non-Executive Director Neil Herskowitz |
SEC filings
Date | Form | Event |
---|---|---|
6 Dec, 2024 | DEF 14A | |
2 Dec, 2024 | 424B3 | |
27 Nov, 2024 | EFFECT | |
22 Nov, 2024 | S-3 | |
15 Nov, 2024 | 8-K | |
14 Nov, 2024 | SC 13G/A | |
8 Nov, 2024 | 10-Q | |
6 Nov, 2024 | 8-K | |
29 Oct, 2024 | 3 | |
25 Oct, 2024 | 8-K | |
13 Sep, 2024 | 8-K | |
16 Aug, 2024 | 424B5 | |
13 Aug, 2024 | 10-Q | |
29 Jul, 2024 | EFFECT | |
25 Jul, 2024 | CORRESP | |
25 Jul, 2024 | UPLOAD | |
19 Jul, 2024 | S-1 | |
10 Jul, 2024 | DEF 14C | |
3 Jul, 2024 | 424B5 | |
3 Jul, 2024 | 8-K | |
28 Jun, 2024 | PRE 14C | |
28 Jun, 2024 | SC 13D/A | |
28 Jun, 2024 | 4 | |
24 Jun, 2024 | 8-K | |
24 Jun, 2024 | D | |
21 Jun, 2024 | 424B5 | |
20 Jun, 2024 | 424B5 | |
12 Jun, 2024 | EFFECT | |
10 Jun, 2024 | CORRESP | |
6 Jun, 2024 | 8-K | |
4 Jun, 2024 | 4 | |
4 Jun, 2024 | UPLOAD | |
4 Jun, 2024 | 4 | |
31 May, 2024 | S-3 | |
21 May, 2024 | 8-K | |
15 May, 2024 | 10-Q | |
13 May, 2024 | 424B3 | |
2 May, 2024 | 8-K | |
1 May, 2024 | 424B4 | |
29 Apr, 2024 | CORRESP | |
29 Apr, 2024 | CORRESP | |
29 Apr, 2024 | CORRESP | |
29 Apr, 2024 | 8-K | |
29 Apr, 2024 | EFFECT | |
29 Apr, 2024 | S-1/A | |
29 Apr, 2024 | EFFECT | |
29 Apr, 2024 | S-1/A | |
29 Apr, 2024 | S-1/A | |
12 Apr, 2024 | 8-K | |
2 Apr, 2024 | S-1/A | |
29 Mar, 2024 | 8-K | |
20 Mar, 2024 | UPLOAD | |
15 Mar, 2024 | 8-K | |
15 Mar, 2024 | S-1 | |
11 Mar, 2024 | 8-K | |
11 Mar, 2024 | 10-K | |
14 Feb, 2024 | SC 13G | |
14 Feb, 2024 | 8-K | |
12 Feb, 2024 | 3 | |
25 Jan, 2024 | 8-K | |
4 Jan, 2024 | 8-K | |
3 Jan, 2024 | 4 | |
19 Dec, 2023 | 3 | |
18 Dec, 2023 | UPLOAD | |
12 Dec, 2023 | 8-K | CEO Change |
12 Dec, 2023 | S-1 | |
11 Dec, 2023 | 8-K | |
14 Nov, 2023 | 8-K | |
14 Nov, 2023 | 10-Q | |
3 Nov, 2023 | D | |
2 Nov, 2023 | 8-K | |
30 Oct, 2023 | 8-K | |
30 Oct, 2023 | 424B5 | |
26 Oct, 2023 | 8-K | |
4 Oct, 2023 | 8-K | |
6 Sep, 2023 | UPLOAD | |
28 Aug, 2023 | CORRESP | |
23 Aug, 2023 | UPLOAD | |
16 Aug, 2023 | 8-K | |
14 Aug, 2023 | 8-K | |
14 Aug, 2023 | 10-Q | |
1 Aug, 2023 | S-8 | |
31 Jul, 2023 | 8-K | |
20 Jul, 2023 | 8-K | |
11 Jul, 2023 | 8-K | |
7 Jul, 2023 | 4 | |
7 Jul, 2023 | 4 | |
7 Jul, 2023 | 4 | |
7 Jul, 2023 | 4 | |
7 Jul, 2023 | 4 | |
7 Jul, 2023 | 4 | |
30 Jun, 2023 | 8-K | |
23 Jun, 2023 | 8-K | |
22 May, 2023 | 8-K | |
12 May, 2023 | 10-Q | |
12 May, 2023 | 8-K | |
28 Apr, 2023 | DEFA14A | |
28 Apr, 2023 | DEF 14A | |
20 Apr, 2023 | 8-K | |
14 Apr, 2023 | 424B5 | |
13 Apr, 2023 | 8-K | |
6 Apr, 2023 | 3/A | |
6 Apr, 2023 | 3/A | |
3 Apr, 2023 | 8-K | |
3 Apr, 2023 | 4 | |
3 Apr, 2023 | 4 | |
3 Apr, 2023 | 4 | |
3 Apr, 2023 | 4 | |
3 Apr, 2023 | 4 | |
3 Apr, 2023 | 4 | |
30 Mar, 2023 | 10-K | |
29 Mar, 2023 | 8-K | |
13 Mar, 2023 | DEF 14C | |
3 Mar, 2023 | 8-K | |
3 Mar, 2023 | PRE 14C | |
13 Jan, 2023 | SC 13D/A | |
6 Jan, 2023 | 4 | |
13 Dec, 2022 | 8-K | |
14 Nov, 2022 | 10-Q | |
14 Nov, 2022 | 8-K | |
11 Aug, 2022 | 8-K | |
11 Aug, 2022 | 10-Q | |
15 Jul, 2022 | S-8 | |
8 Jul, 2022 | SC 13G | |
7 Jul, 2022 | 8-K | |
24 Jun, 2022 | 8-K | |
7 Jun, 2022 | 3 | |
31 May, 2022 | 8-K | |
12 May, 2022 | 10-Q | |
12 May, 2022 | 8-K | |
29 Apr, 2022 | DEFA14A | |
29 Apr, 2022 | DEF 14A | |
22 Apr, 2022 | 8-K | |
19 Apr, 2022 | PRE 14A | |
23 Mar, 2022 | 10-K | |
23 Mar, 2022 | 8-K | |
17 Mar, 2022 | 8-K | |
8 Mar, 2022 | 8-K | |
4 Feb, 2022 | SC 13G | |
16 Dec, 2021 | 4 | |
12 Nov, 2021 | 10-Q | |
12 Nov, 2021 | 8-K | |
8 Nov, 2021 | 4 | |
21 Oct, 2021 | 4 | |
28 Sep, 2021 | 8-K | |
24 Sep, 2021 | 4 | |
24 Sep, 2021 | 8-K | |
24 Sep, 2021 | 4 | |
16 Aug, 2021 | 8-K | |
16 Aug, 2021 | 10-Q | |
5 Aug, 2021 | 4 | |
30 Jul, 2021 | S-8 | |
30 Jul, 2021 | S-8 | |
8 Jul, 2021 | 4 | |
8 Jul, 2021 | 4 | |
8 Jul, 2021 | 4 | |
8 Jul, 2021 | 4 | |
8 Jul, 2021 | 4 | |
8 Jul, 2021 | 4 | |
22 Jun, 2021 | 8-K | |
15 Jun, 2021 | PX14A6G | |
24 May, 2021 | EFFECT | |
20 May, 2021 | CORRESP | |
20 May, 2021 | S-3/A | |
14 May, 2021 | 8-K | |
14 May, 2021 | 10-Q | |
30 Apr, 2021 | DEF 14A | |
30 Apr, 2021 | DEFA14A | |
29 Apr, 2021 | 4 | |
28 Apr, 2021 | UPLOAD | |
23 Apr, 2021 | S-3 | |
20 Apr, 2021 | PRE 14A | |
16 Apr, 2021 | 4 | |
12 Apr, 2021 | SC 13G/A | |
2 Apr, 2021 | S-8 | |
24 Mar, 2021 | 10-K | |
24 Mar, 2021 | 8-K | |
15 Mar, 2021 | 4 | |
15 Mar, 2021 | 4 | |
15 Mar, 2021 | 4 | |
2 Feb, 2021 | SC 13G | |
2 Dec, 2020 | CORRESP | |
2 Nov, 2020 | UPLOAD |
Last update:2025-03-06 12:11:58.196135
Sign Up to Subscribe
Interested in special situations?
Join Tickerverse
- customize event filters
- create watchlists, bookmarks
- get email notifications for the latest special situations
- browse and analyze public companies, executives and SEC filings
Tickerverse is a great way to find investment opportunities in corporate actions.
By signing up you agree to our Terms of Service and Privacy Policy.